F-Prime Capital — 2019 Investments
2 investments dated 2019 · listed companies and verified rows first · show all
Activating the immune system to recognize and destroy tumor cells.
BiotechCambridge, US
Art Krieg(Executive Officer, Director)Barry Labinger(Executive Officer, Director)Chuck Abdalian(Executive Officer)David Mauro(Executive Officer)Karen Brennan(Executive Officer)Charles Yon(Executive Officer)
Board seatRobert Weisskoff· per SEC Form D
Co-investorsSofinnova VenturesLongitude CapitalNovo Holdings
Artemis Health provides data analytics and insights software to U.S. employers, advisors, and payers to optimize health benefits and reduce healthcare costs.
Data & InfrastructureEnterprise SoftwareHealthtechSalt Lake City, US
Grant Gordon(Executive Officer, Director)inDallen Allred(Executive Officer, Director)Dallin Regehr(Executive Officer)Dallin Preston Regehr(Executive Officer, Director)
BoardDalton Wright(Director)inJon Lim(Director)in
Co-investorsBessemer Venture PartnersKickstartValence VenturesMaverick Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.